Argent Biopharma (STU:H5O0) Debt-to-Equity : -0.20 (As of Jun. 2024)

Argent Biopharma Debt-to-Equity Chart

Argent Biopharma Annual Data
	Trend	Jun15	Jun16	Jun17	Jun18	Jun19	Jun20	Jun21	Jun22	Jun23	Jun24
Debt-to-Equity		Get a 7-Day Free Trial					0.61	0.44	0.75	-0.08	-0.20

Argent Biopharma Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Debt-to-Equity	Get a 7-Day Free Trial															0.75	-1.10	-0.08	0.35	-0.20

Competitive Comparison of Argent Biopharma's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Argent Biopharma's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Argent Biopharma's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Argent Biopharma's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Argent Biopharma's Debt-to-Equity falls into.

Argent Biopharma Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Argent Biopharma's Debt to Equity Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Argent Biopharma's Debt to Equity Ratio for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Argent Biopharma  (STU:H5O0) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Argent Biopharma Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Argent Biopharma's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Argent Biopharma Business Description